- Home
- ITOS vs HYI Comparison
ITOS vs HYI Comparison
Compare ITOS & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- HYI
- Stock Information
- Founded
- ITOS 2011
- HYI 2010
- Country
- ITOS United States
- HYI United States
- Employees
- ITOS N/A
- HYI N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- HYI Investment Managers
- Sector
- ITOS Health Care
- HYI Finance
- Exchange
- ITOS Nasdaq
- HYI Nasdaq
- Market Cap
- ITOS 323.2M
- HYI 279.2M
- IPO Year
- ITOS 2020
- HYI N/A
- Fundamental
- Price
- ITOS $9.17
- HYI $12.19
- Analyst Decision
- ITOS Strong Buy
- HYI
- Analyst Count
- ITOS 4
- HYI 0
- Target Price
- ITOS $32.50
- HYI N/A
- AVG Volume (30 Days)
- ITOS 692.7K
- HYI 50.6K
- Earning Date
- ITOS 11-15-2024
- HYI 01-01-0001
- Dividend Yield
- ITOS N/A
- HYI 9.59%
- EPS Growth
- ITOS N/A
- HYI N/A
- EPS
- ITOS N/A
- HYI N/A
- Revenue
- ITOS $35,000,000.00
- HYI N/A
- Revenue This Year
- ITOS $271.18
- HYI N/A
- Revenue Next Year
- ITOS N/A
- HYI N/A
- P/E Ratio
- ITOS N/A
- HYI N/A
- Revenue Growth
- ITOS N/A
- HYI N/A
- 52 Week Low
- ITOS $8.41
- HYI $10.99
- 52 Week High
- ITOS $18.75
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- ITOS 46.37
- HYI 50.03
- Support Level
- ITOS $8.41
- HYI $12.12
- Resistance Level
- ITOS $9.14
- HYI $12.25
- Average True Range (ATR)
- ITOS 0.49
- HYI 0.09
- MACD
- ITOS 0.21
- HYI 0.01
- Stochastic Oscillator
- ITOS 71.58
- HYI 57.58
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.